Finance

Beta
Lists
MOB:STO
Moberg Pharma AB (publ)
9,96 SEK
+0,10%
(+0,010) 1D
5-июн., 17:29:32 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for MOB...
Open
9,80 SEK
High
10,10 SEK
Low
9,80 SEK
Mkt. cap
485,17 млн
Avg. vol.
157,16 миң
Volume
26,75 миң
52-wk high
14,12 SEK
52-wk low
7,53 SEK
EPS
-0,55 SEK
Shares outstanding
48,71 млн
No. of employees
5
Open
9,80 SEK
High
10,10 SEK
Low
9,80 SEK
Mkt. cap
485,17 млн
Avg. vol.
157,16 миң
Volume
26,75 миң
52-wk high
14,12 SEK
52-wk low
7,53 SEK
EPS
-0,55 SEK
Shares outstanding
48,71 млн
No. of employees
5
News stories
From sources across the web
About Moberg Pharma AB (publ)
CEO-
Employees5
Founded2006
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
3,60 млн
4,00 млн
2,07 млн
4,92 млн
Cost of goods sold
1,90 млн
1,59 млн
1,07 млн
1,66 млн
Cost of revenue
1,90 млн
1,59 млн
1,07 млн
1,66 млн
Research and development expenses
1,07 млн
555,00 миң
1,34 млн
1,59 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,32 млн
7,98 млн
7,10 млн
6,05 млн
Operating expense
11,43 млн
8,42 млн
9,13 млн
5,12 млн
Total operating expenses
13,33 млн
10,00 млн
10,20 млн
6,78 млн
Operating income
-9,73 млн
-6,00 млн
-8,13 млн
-1,86 млн
Other non operating income
-
-
-
-
EBT including unusual items
-8,70 млн
-5,18 млн
-6,96 млн
-1,23 млн
EBT excluding unusual items
-8,70 млн
-5,18 млн
-6,96 млн
-1,23 млн
Income tax expense
-1,30 млн
-859,00 миң
5,80 млн
33,00 миң
Effective tax rate
14,98%
16,60%
-83,34%
-2,68%
Other operating expenses
33,00 миң
-119,00 миң
694,00 миң
-2,52 млн
Net income
-7,39 млн
-4,32 млн
-12,76 млн
-1,26 млн
Net profit margin
-205,62%
-107,79%
-616,78%
-25,66%
Earnings per share
-0,16
-0,09
-
-
Interest and investment income
1,08 млн
865,00 миң
533,00 миң
663,00 миң
Interest expense
-47,00 миң
-42,00 миң
-37,00 миң
-32,00 миң
Net interest expenses
1,03 млн
823,00 миң
496,00 миң
631,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,56 млн
-5,83 млн
-7,93 млн
-1,46 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more